In the latest guideline (2018) from the College of American Pathologists/International Association for the Study of Lung Cancer/Association of Molecular Pathology, EGFR is indicated as a necessary testing gene for lung adenocarcinoma, and KRAS is a recommended testing gene, especially in cases where routine tests for EGFR show negative results [12]. Here, KRAS is linked to lung adenocarcinoma.